U.S. Water Crisis (II): The Eternal Toxin

Data Sources Data Point Source Kelly Calhoun, a housewife from Calhoun; daily consumption of sweet tea; self-funded blood test in 2019; neighbors and friends died of cancer FRONTLINE / Associated Press / Atlanta Journal-Constitution joint documentary 'Contaminated: The Carpet Industry’s Toxic Legacy', February 2026 Calhoun’s 50-year exposure to PFAS-contaminated drinking water affecting 200,000 residents; 30% higher cancer incidence Ibid.; Dalton State College’s 2008 study on PFAS detection in local water sources Dalton carpet manufacturers sprayed PFAS-laden wastewater across 9,600 acres of forestland; downstream contamination sustained for 100 years FRONTLINE’s 'Contaminated', February 2026; Tencent News, May 2026 1938: Roy Plunkett at DuPont accidentally discovered polytetrafluoroethylene (PTFE); 1944: 'Teflon' trademark registered; used as seals in the Manhattan Project; 1961: non-stick cookware launched commercially DuPont official corporate history; ProPublica’s series 'The Teflon Toxin' DuPont’s Teflon-related business generated over $1 billion in annual net profit DuPont annual reports; ProPublica investigation 1961: internal DuPont toxicology report noted enlarged livers in rats; 1981: 3M’s internal report documented 7 female workers exposed—2 gave birth to severely disabled infants; 1990: rat testicular tumors observed; 1993: cost-benefit analysis concluded against switching to safer alternatives 110,000 pages of internal DuPont documents obtained by attorney Robert Bilott via court-ordered injunction in 2000; ProPublica’s 'The Teflon Toxin' 1998: 153 of 600 cattle died at Tennant Farm in West Virginia; linked to waste disposal site at DuPont’s Washington Works plant Ibid.; case materials underlying the film 'Dark Waters' 2000: attorney Robert Bilott filed motion for injunction and secured access to 110,000 pages of internal DuPont documents DeSmog long-form report; film 'Dark Waters' (2019) PFAS exposure linked to thyroid cancer, kidney cancer, testicular cancer, immune dysfunction, fetal death or disability; half-life of long-chain PFAS compounds spans decades NIH PubMed reviews; EPA’s PFAS Health Risk White Paper; IARC carcinogen assessment 176 million Americans’ public drinking water contains detectable PFAS; 1,050 water systems exceed health advisory levels; 52 million people served EPA 2025 public data; Sina Kandian, May 2026 97% of Americans tested by CDC show detectable PFAS levels in blood CDC NHANES national sampling data; CDC PFAS Health Brief PFAS exposure adds $5.7 billion annually to U.S. healthcare expenditures Trasande team, NYU Langone Health, journal 'Exposure and Health', 2023 Rome, GA: $100 million PFAS treatment plant; Anaheim, CA: $200 million; Calhoun, GA: filtration facility construction began in 2024 China News Service, February 2026; Sina Kandian, May 2026; City of Rome, GA City Council resolution Rome municipal bond interest rate: 4.2%; 30-year repayment term; average monthly water bill increased from $35 to $58; share of household disposable income rose from 0.8% to 1.4% Ibid. Home reverse-osmosis system: $600 upfront; annual filter replacement: $200; blood testing per session: $300 EWG Tap Water Database; resident testimonials (FRONTLINE documentary) DuPont founded in 1802 in Wilmington, DE; began purchasing PFOA from 3M in 1951 DuPont official corporate history; ProPublica’s 'The Teflon Toxin' 3M announced phaseout of PFOA in 2002; DuPont continued production—and expanded output—at its Fayetteville Works plant in North Carolina EPA public archives; ProPublica investigation 2005: EPA fined DuPont $16.5 million—the maximum statutory penalty allowed under federal law at the time EPA press release, December 2005 2017: DuPont settled for $671 million with 3,500 residents in Ohio and West Virginia Reuters, February 2017; ProPublica 2015: DuPont spun off Chemours (assumed $4 billion debt and 3,500 pending PFAS lawsuits); 2019: spun off Corteva DuPont SEC Form 8-K filings; Chemours 2015 IPO prospectus 2021: liability allocation finalized—Chemours: 50%; DuPont: 35.5%; Corteva: 14.5% Chemours 2021 announcement; SEC filings DuPont cumulative settlement payments: $671 million (2017); $40 million (Abbott case, 2020); $1.18 billion (2023); $27 million (Hoosick Falls, July 2025); $875 million (New Jersey, August 2025) Reuters; New Jersey Attorney General’s Office announcements DuPont’s highest recent annual revenue: $13 billion DuPont 2024 Form 10-K report UN Human Rights Council investigator statement, 2024 UN OHCHR public statement, September 2024 April 2024: Biden administration EPA issued first-ever national enforceable drinking water limits for six PFAS compounds; monitoring required by 2027; compliance required by 2029; full enforcement effective 2031 EPA official announcement, April 2024 First new enforceable limit added to the Safe Drinking Water Act since its 1996 amendment EPA historical archives May 2025: Trump-era EPA revoked four of the six limits, retained two, and extended compliance deadlines to 2031 Sigma Earth, 2025; Weidu Network, May 2025; EPA press release, May 2025 December 2024: The Guardian reported EPA accelerated approval of novel short-chain PFAS for semiconductor industry use The Guardian, December 2024 Love Canal: Hooker Chemical dumped 21,800 tons of chemical waste (including DDT, dioxin, hexachlorobenzene) between 1942–1953; sold site to Niagara Falls Board of Education on April 28, 1953, for $1—with liability waiver clause Economic Observer, December 2023; EPA Superfund record NYD000606947; NYT, August 3, 1978 1976: black sludge seeped into basements near school grounds; 1978: President Carter declared federal emergency; 950 households evacuated Niagara Gazette investigative reporting by Michael Brown, 1976–1978; Carter Presidential Library emergency declaration archives 1980: Comprehensive Environmental Response, Compensation, and Liability Act ('Superfund Act') established strict, joint-and-several, retroactive liability for polluters; 1995: Occidental Petroleum settled for $129 million; cleanup lasted 24 years and cost over $400 million Ibid.; EPA Superfund archives General Electric PCB contamination; PG&E hexavalent chromium contamination EPA Hudson River Project archives; film 'Erin Brockovich' EWG 2024 compilation of 50,000 U.S. public water systems; 320+ contaminants identified; over 200 lacking federal enforceable limits EWG Tap Water Database 2024 Report November 2023: International Agency for Research on Cancer (IARC) classified PFAS as Group 1 carcinogens IARC Monographs Volume 135 (November 2023)

Key Litigation Points in Securities Fraud Misrepresentation Liability Disputes

For the broad investor community, how can one effectively pursue legal remedies after suffering losses due to listed companies’ financial fraud or disclosure violations? The Supreme People’s Court’s 'Provisions on Several Issues Concerning the Trial of Civil Compensation Cases Involving False Statements in the Securities Market' (Judicial Interpretation [2022] No. 2) abolished the administrative prerequisite procedure: investors may now file lawsuits directly—without awaiting an administrative penalty decision—significantly lowering the threshold for redress. Drawing upon our team’s litigation experience and recent judicial precedents, this article outlines core procedural and substantive points in such cases, aiming to provide practical guidance. I. Competent Court and Cause of Action Securities fraud liability disputes include: insider trading liability disputes, market manipulation liability disputes, securities false statement liability disputes, and client fraud liability disputes. Among these, securities false statement liability disputes refer to civil compensation claims arising from tortious acts committed by information-disclosing obligors during the issuance or trading of securities on regulated exchanges. Jurisdiction lies with intermediate people’s courts—or specialized courts—located in cities hosting provincial-level governments, sub-provincial cities, or special economic zones, where the issuer is domiciled. For example, in Beijing, all first-instance securities false statement liability disputes filed over the past five years have been assigned exclusively to the Beijing Financial Court. II. Litigants (A) Eligible Plaintiffs in Securities False Statement Civil Compensation Cases Eligible plaintiffs include investors, security holders, trustees, and asset management product managers. 'Investors' and 'holders' encompass investment products lawfully established by market participants—including securities firms, fund management companies, insurance companies, trust companies, and commercial banks. (B) Liable Parties III. Types of False Statements IV. Loss Assessment The scope of civil compensation liability borne by information-disclosing obligors is limited to plaintiffs’ actual losses resulting directly from the false statement. Such losses specifically include: (A) Investment differential loss (B) Commission fees (0.03%) and stamp duty (0.1%) attributable to the investment differential loss In securities false statement liability disputes, the 'Three Dates and One Price' refer to: the date of implementation of the false statement, the date of disclosure (or correction), the benchmark date for calculating investment differential loss, and the benchmark price for calculating investment differential loss. Date of Implementation: the day on which the information-disclosing obligor made the false statement—or the day the false statement occurred.

Chemours Faces Securities Lawsuit Over Disclosures and Guidance

1 day ago

Chemours Co faces a securities class action lawsuit concerning Opteon demand and 2026 financial guidance disclosures. While investors view the stock as undervalued at $13.61 versus an $18.56 fair value, PFAS settlements and TiO2 pricing remain key risks.

Simply Wall Street

2026-10-09

Chemours Company Faces Securities Fraud Class Action Over Opteon Demand Claims

2026-10-11

Chemours Faces Securities Lawsuit Over Disclosures and Guidance

2026-10-12

Class Action Lawsuit Filed Against Chemours for Misleading Investors on Product Demand and Financial Guidance.

Chemours Faces Securities Lawsuit Over Disclosures and Guidance

FAQ